Episode Details
Back to Episodes
Episode 504: ASCO 2026 - ADC Drug Development in Urothelial Cancer
Published 4 months, 3 weeks ago
Description
This episode with Gopa Iyer from MSKCC explores the latest advances in antibody drug conjugates (ADCs) in urothelial cancer, including data from EV302, novel ADCs targeting Nectin-4, and sequencing strategies. Experts discuss efficacy, safety, biomarkers, and future directions in bladder cancer treatment.